Dr. Michael L Rubinstein

D.D.S. | Dentist



  
  362 Ives St, Providence
  Rhode Island, 02906-3929

  401-861-4358    Maps & Directions
Dr. Michael L Rubinstein is a Providence, Rhode Island based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 362 Ives St, Providence. Patients can reach him at 401-861-4358.
Dr. Michael L Rubinstein is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Michael L Rubinstein speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Michael L Rubinstein
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:362 Ives St, Providence,
Rhode Island, 02906-3929
Phone:401-861-4358
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 2567744998
Enrollment ID: I20170120000024
NPI Number: 1164517959
NPI Enumeration Date: 04 Oct, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 362 Ives St,
Providence, Rhode Island
Zip: 02906-3929
Phone Number: 401-861-4358
Patients can reach Dr. Michael L Rubinstein at 362 Ives St, Providence, Rhode Island or can call to book an appointment on 401-861-4358. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.

Comments/ Reviews: